Riskpilot← Back to searchSign inGet full accessMartina Schmidt Med Konsult AB
ABActiveOrg 5590993407StockholmMedical specialists activities · NACE 8622Est. 20170 employees
Revenue 2025
SEK 0
EBITDA margin
—
-188% vs 2024
Equity ratio
90.7%
Financial strength
Net profit 2025
SEK 225K
+131% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -20K | -188% |
| Net profit | SEK 225K | +131% |
| Total assets | SEK 492K | -26% |
| Equity | SEK 446K | +45% |
| Employees | 0 | — |
Legal name
Martina Schmidt Med Konsult AB
Org number
5590993407
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 februari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom läkar- och vårdområdet, utbildning, lednings- och styrelseuppdrag, äga och förvalta lös egendom, värdepapper och fastigheter samt därmed förenlig verksamhet.
Address
Stockholm
Email
martina777@gmx.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 110 | 110 | 158 | 55 | 0 |
| Staff expenses | — | −0 | −3 | −1 | −0 |
| EBITDA | 106 | 80 | 114 | 23 | −20 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 106 | 80 | 114 | 23 | −20 |
| Net financials | −3 | 10 | 5 | 10 | −2 |
| Profit before tax | 77 | 68 | 164 | 127 | 287 |
| Tax | −17 | −14 | −38 | −30 | −62 |
| Net profit | 60 | 54 | 126 | 97 | 225 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 927 | 993 | 866 | 666 | 492 |
| Equity | 460 | 514 | 400 | 307 | 446 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 40 | 30 | 62 | 49 | 46 |
| Total debt | 40 | 30 | 62 | 49 | 46 |
EBITDA margin
-2023900.0%
This company
15.8%
Market median
-12809594% vs market
20212025
Equity ratio
90.7%
This company
38.2%
Market median
+137% vs market
20212025
Return on equity
50.4%
This company
18.4%
Market median
+174% vs market
20212025
Net profit margin
22488700.0%
This company
8.1%
Market median
+277638172% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Authorized Recipient of Service | Authorized Recipient of Service | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Martina Schmidt Med Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Erik Lindqvist | Authorized Recipient of Service | 0 companies |
| Martina Erika Gisela Schmidt | Board of Directors | 0 companies |
| Lara Meimouna Mbaye | Deputy Board Member | 0 companies |